BioSpace News Archive

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its first quarter 2023 financial results on Monday, May 15th.

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for PMN310 for the treatment of AD.

Amgen (NASDAQ:AMGN) today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia® (denosumab) injection reduced fracture risk in patients versus oral alendronate, a frequently prescribed bisphosphonate treatment.

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its second quarter of the fiscal year 2023 ended on March 31, 2023, on May 15, 2023, beginning at 1:30 pm PT.

Mammoth Biosciences today announced Janice Chen, Ph.D., chief technology officer and co-founder of Mammoth, will present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles, CA, May 16 - 20, 2023.

ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, announced the launch of its enhanced, next-generation Eureka Clinical AI platform.

Singlera Genomics today announced that it had received Breakthrough Device Designation from the Food and Drug Administration (FDA) for its PDACatch assay, a novel DNA methylation-based liquid biopsy assay for the detection of pancreatic adenocarcinoma in individuals at high risk for the disease.

Baxter International Inc., a leading global medtech company, announced that it has signed a definitive agreement to divest its BioPharma Solutions business to Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

The Insight Partners published latest research report on “GMP Cytokines Market Size Report, Share, Trends, Growth & Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, and Application, and Geography”, the global market size is expected to reach USD 158.13 million in 2027 from USD 84.72 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027.

The Insight Partners published latest research report on “Neurovascular Devices Market Size Report, Trends, Share & Growth Forecast to 2027 – COVID-19 Impact and Global Analysis - by Product, Application; and End User”, the global market is expected to reach USD 3,871.20 million by 2027 from USD 2,997.36 million in 2019; it is expected to grow at a CAGR of 3.2% from 2020 to 2027.